Page 23 - Contributed Paper Session (CPS) - Volume 4
P. 23

CPS2106 Julio M. Singer et al.


























                This algorithm, adapted from Muggeo et al. (2014), essentially considers
            iterative  fitting  of  standard  linear  mixed  models  by  restricted  maximum
            likelihood. At convergence, we expect a neglible difference between the third
            and fourth terms in the right hand side of (2) and as a consequence, that the
            pseudo  observations should  well  approximate  the  original  ones.  Given the
            linear mixed model nature of the proposed fitting algorithm, we may employ
            the diagnostic procedures outlined in Singer et al. (2017) to check whether the
            adopted  assumptions  for  the  distribution  of  the  random  effects  or  of  the
            random error are reasonable.
                Estimates  of  the  parameters  of  model  (1)  obtained  via  fitting  the
            approximation  (2)  along  with  the  corresponding  standard  errors  are
            summarized in Table (1).
                The results of a Wald test for the homogeneity of the six changepoints ψ1
              2
            (χ = 58.30,df = 5,p < 0.001) suggests further analyses to identify the possible
            effects  of  treatment,  sex  and  their  interaction.  A  significant  interaction
            between treatment and sex with respect to the ψ1 changepoints (χ = 13.65,df
                                                                            2
            = 2,p = 0.001) may be analysed via the multiple comparisons summarized in
            Table 2 and suggest that the onset of symptoms for the control group (HBSS)
            males is delayed by 1.7 [CI(95%) = 1.0, 2.4] weeks with respect to the control
            group females and that treatment with Pericytes (both sexes) or MSC (females)
            delay the onset of symptoms by 1.3 [CI(95%) = 0.5, 2.2] weeks with respect to
            HBSS  treated males.  The  changepoint  for MSC treated  males  lies  between
            those for HBSS treated males and females but the small sample size does not
            lead to a significant difference in either case.
                The  results  for  a  similar  analysis  of  the  acceleration  with  which  the
            symptom progresses suggest no difference between sexes and an increase in
                                                                  2
            the acceleration of 18.6 [CI(95%) = 17.8, 19.6] sec/week for the experimental

                                                                12 | I S I   W S C   2 0 1 9
   18   19   20   21   22   23   24   25   26   27   28